In their observational study, Crescioli et al. found that the SNPs of IL6 (rs1800797) and TNF (rs1800629) may serve as possible indicators of baseline pain severity and opioid dosage requirements among pediatric cancer patients [40]. This evidence concerns the gene IL6 and cancer.